Compass Pathways Plc Equity-NMS: CMPS

$- -4.34 (January 1, 1970)

Healthcare

Medical Care Facilities

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$4.34
Open :$4.25
Today's high :$4.29
Today's low :$4.1
52W low :$2.49
52W high :$8.5367
EPS(TTM): :-1.99
Shares O/S :93.56 M
Market cap :391.09 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Compass Pathways Plc $- -0% - 391.09M

Frequently Asked Questions

What is the share price of Compass Pathways Plc today?

Compass Pathways Plc (CMPS) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Compass Pathways Plc

Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.